Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative Inhaled Nitric Oxide to Reduce Postoperative AKI in Cardiac Surgery
NCT07544147Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Apr 2026
- Primary completion
- Oct 2028
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
Randomised, double-blind trial in acute kidney injury (AKI) comparing Inhaled Nitric Oxide (iNO) Group with Placebo Group (2 arms). Primary endpoint: Incidence of Acute Kidney Injury at 7 days. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
nitric oxide
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT07544147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07544147.